AKBA Akebia Therapeutics, Inc. - Common Stock
AKBA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
AKBA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
AKBA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
- Mocne kupno 5 45,5%
- Kup 5 45,5%
- Trzymaj 1 9,1%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
5 analityków · 2026-08-15Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.03 | $-0.04 | 0.01% |
| 31 marca 2026 | $-0.03 | $-0.03 | -0.00% |
| 31 grudnia 2025 | $-0.05 | $-0.03 | -0.02% |
| 30 września 2025 | $0.00 | $-0.02 | 0.02% |
| 30 czerwca 2025 | $0.00 | $-0.02 | 0.02% |
| 31 marca 2025 | $0.03 | $-0.05 | 0.08% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| CNXU | — | — | — | — | — | — |
| GLSI | $300M | -14.7 | — | — | -2159.7% | — |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| NBP | — | — | — | — | — | — |
| IMUX | — | -0.9 | — | — | — | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $236M | $160M | $195M | $292M | $212M | $295M | $335M | $208M | $181M | $2M | $0 | $0 | |
| Cost of Revenue | $39M | $63M | $74M | $86M | $151M | $296M | $145M | $8M | · | · | · | · | |
| R&D Expense | $62M | $38M | $63M | $130M | $148M | $218M | $323M | $291M | $231M | $116M | $43M | $23M | |
| SG&A Expense | $107M | $107M | $100M | $139M | $174M | $154M | $149M | $87M | $27M | $22M | $18M | $15M | |
| Operating Expenses | $173M | $147M | $167M | $288M | $325M | $376M | $476M | $378M | $258M | $138M | $62M | $38M | |
| Operating Income | $23M | $-50M | $-46M | $-81M | $-265M | $-378M | $-286M | $-178M | $-77M | $-136M | $-62M | $-38M | |
| Interest Income | · | · | · | · | · | · | · | · | · | $901.0K | $510.0K | $206.0K | |
| Other Non-op | $58.0K | $94.0K | $887.0K | $3M | $2M | $2M | $-794.0K | $81.0K | $204.0K | $-188.0K | $287.0K | $700.0K | |
| Pretax Income | $-4M | $-69M | $-52M | $-94M | $-282M | $-385M | $-286M | $-172M | $-74M | $-136M | · | · | |
| Income Tax | $2M | $0 | $0 | $0 | $0 | $0 | $-7M | $-28M | · | · | · | · | |
| Net Income | $-5M | $-69M | $-52M | $-94M | $-282M | $-385M | $-280M | $-144M | $-74M | $-136M | $-61M | $-37M | |
| EPS (Basic) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | · | · | · | · | · | |
| EPS (Diluted) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | · | · | · | · | · | |
| Shares (Basic) | 257,157,782 | 210,946,658 | 187,465,448 | 182,782,680 | 165,949,695 | 138,463,152 | 118,395,919 | · | · | · | · | · | |
| Shares (Diluted) | 257,157,782 | 210,946,658 | 187,465,448 | 182,782,680 | 165,949,695 | 138,463,152 | 118,395,919 | · | · | · | · | · | |
| EBITDA | $23M | $-50M | $-46M | $-79M | $-263M | $-374M | $-284M | $-177M | $-79M | $-136M | $-62M | $-38M |
Bilans 29
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $185M | $52M | $43M | $90M | $150M | $229M | $147M | $105M | $70M | $187M | $50M | $33M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $248M | $73M | $89M | $76M | |
| Receivables | $47M | $34M | $39M | $40M | $52M | $27M | $39M | $17M | $34M | $34M | · | $48.0K | |
| Inventory | $16M | $16M | $16M | $22M | $37M | $61M | $116M | $114M | · | · | · | · | |
| Prepaid Expense | $5M | $11M | $20M | $33M | $33M | $15M | $7M | $16M | $6M | $2M | $3M | $2M | |
| Other Current Assets | $4M | $7M | $6M | $17M | · | · | · | · | · | · | · | · | |
| Current Assets | $253M | $114M | $118M | $185M | $271M | $371M | $310M | $468M | $358M | $296M | $141M | $110M | |
| PP&E (Net) | $1M | $2M | $4M | $5M | $7M | $9M | $10M | $8M | $4M | $3M | $540.0K | $210.0K | |
| PP&E (Gross) | · | · | · | $15M | $14M | $14M | $14M | $10M | $5M | $3M | $687.0K | $261.0K | |
| Accum. Depreciation | · | · | · | $9M | $8M | $6M | $4M | $2M | $1M | $442.0K | $147.0K | $51.0K | |
| Goodwill | $59M | $59M | $59M | $59M | $59M | $55M | $55M | $55M | · | · | · | · | |
| Intangibles | · | $0 | $36M | $72M | $108M | $144M | $291M | $328M | · | · | · | · | |
| Other Non-current Assets | $60M | $37M | $12M | $5M | $50M | $38M | $76M | $137M | $2M | $1M | $1M | $305.0K | |
| Total Assets | $377M | $221M | $242M | $356M | $529M | $644M | $771M | $997M | $364M | $300M | $143M | $111M | |
| Accounts Payable | $21M | $15M | $15M | $18M | $34M | $41M | $39M | $43M | $7M | $2M | $2M | $2M | |
| Accrued Liabilities | $122M | $63M | $68M | $76M | $109M | $131M | $129M | $151M | $52M | $30M | $10M | $5M | |
| Current Liabilities | $163M | $81M | $100M | $130M | $261M | $187M | $208M | $266M | $141M | $114M | $12M | $7M | |
| Capital Leases | $0 | $4M | $9M | $29M | $34M | $25M | $28M | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $5M | $9M | $16M | $84M | $61M | $30M | $30M | $22.0K | $27.0K | $5.0K | $32.0K | |
| Total Liabilities | $344M | $270M | $272M | $351M | $455M | $397M | $376M | $361M | $242M | $232M | $12M | $7M | |
| Long-term Debt | $48M | $39M | $35M | $66M | $98M | $96M | $76M | · | · | · | · | · | |
| Total Debt | $48M | $39M | $35M | · | $98M | $96M | $76M | · | · | · | · | · | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $0 | $0 | $0 | |
| Retained Earnings | $-1.68B | $-1.68B | $-1.61B | $-1.56B | $-1.46B | $-1.18B | $-794M | $-514M | $-371M | $-297M | $-161M | $-101M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $162.0K | $162.0K | |
| AOCI | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $13.0K | $0 | $-261.0K | $-442.0K | $-42.0K | $-234.0K | $-56.0K | |
| Stockholders' Equity | $33M | $-49M | $-31M | $5M | $74M | $244M | $393M | $636M | $123M | $68M | $131M | $104M | |
| Liabilities + Equity | $377M | $221M | $242M | $356M | $529M | $644M | $771M | $997M | $364M | $300M | $143M | $111M | |
| Shares Outstanding | 265,424,818 | 224,848,992 | 194,582,539 | 184,135,714 | 177,000,963 | 148,074,085 | 121,674,568 | 116,887,518 | 47,612,619 | 38,615,709 | 30,662,218 | 20,370,624 |
Przepływy pieniężne 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $2M | $2M | $2M | $2M | $899.0K | $617.0K | $296.0K | $96.0K | $49.0K | |
| Stock-based Comp | $11M | $8M | $9M | $18M | $23M | $24M | $12M | $19M | $9M | $6M | $5M | $6M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-7M | $-28M | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $0 | $36M | $36M | $36M | $36M | $33M | $36M | $2M | · | · | · | · | |
| Restructuring | $0 | $58.0K | $181.0K | $16M | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | $2M | $5M | $247M | $15M | $55M | $11M | $188M | · | · | |
| Operating Cash Flow | $68M | $-41M | $-23M | $-73M | $-253M | $-110M | $-257M | $-97M | $-56M | $58M | $-52M | $-27M | |
| CapEx | $291.0K | $33.0K | $0 | $114.0K | $59.0K | $317.0K | $7M | $2M | $2M | $3M | $414.0K | $229.0K | |
| Investing Cash Flow | $-8M | $-33.0K | $0 | $-114.0K | $40M | $-40M | $211M | $37M | $-177M | $13M | · | · | |
| Debt Issued | · | · | · | $0 | $0 | $20M | $78M | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $0 | $20M | $78M | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $468M | $373M | · | · | $104M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $162.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | $468M | $373M | · | · | $104M | |
| Financing Cash Flow | $73M | $50M | $-25M | $15M | $134M | $232M | $89M | $97M | $116M | $67M | · | · | |
| Net Change in Cash | $133M | $9M | $-49M | $-59M | $-79M | $81M | $43M | $36M | $-117M | $138M | $17M | $12M | |
| Free Cash Flow | $68M | $-41M | $-23M | $-73M | $-253M | $-111M | $-264M | $-99M | $-58M | $55M | $-53M | $-28M |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 10.0% | -31.5% | -23.8% | -27.6% | -124.2% | -127.5% | -85.5% | -85.8% | · | · | · | · | |
| Net Margin | -2.3% | -43.3% | -26.7% | -32.2% | -132.4% | -129.8% | -83.5% | -69.1% | · | · | · | · | |
| Pretax Margin | -1.6% | -43.3% | -26.7% | -32.2% | -132.4% | -129.8% | -85.5% | -82.8% | · | · | · | · | |
| EBITDA Margin | 10.0% | -31.5% | -23.8% | -27.1% | -123.3% | -126.8% | -84.8% | -85.3% | · | · | · | · | |
| ROA | -1.8% | -30.0% | -19.9% | · | -48.4% | -54.2% | -31.6% | -21.1% | -23.2% | -61.3% | -47.8% | -50.8% | |
| ROE | -17.3% | 139.4% | 148.3% | · | -264.8% | -135.6% | -64.9% | -36.9% | -82.1% | -136.3% | -51.7% | 322.1% | |
| ROIC | 41.7% | · | · | · | -152.5% | -109.4% | -59.4% | -23.4% | · | · | · | · |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.4 | 1.2 | · | 1.1 | 2.0 | 1.5 | 1.8 | 2.5 | 2.6 | 11.9 | 16.0 | |
| Quick Ratio | 1.4 | 1.1 | 0.8 | · | 0.8 | 1.4 | 0.9 | 0.5 | 2.4 | 2.3 | 11.7 | 15.8 | |
| Debt / Equity | 1.5 | -0.8 | -1.1 | · | 1.3 | 0.4 | 0.2 | · | · | · | · | · | |
| LT Debt / Equity | 1.5 | -0.8 | -0.6 | · | 0.0 | 0.4 | 0.2 | · | · | · | · | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | · | 0.4 | 0.4 | 0.4 | 0.3 | · | · | 0.0 | 0.0 | |
| Inventory Turnover | 2.5 | 4.0 | 4.1 | · | 3.1 | 3.3 | 0.9 | 0.1 | · | · | · | · | |
| Receivables Turnover | 5.8 | 4.3 | 6.7 | · | 5.5 | 9.0 | 12.1 | 8.2 | · | · | · | 0.0 |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 47.5% | -17.7% | -33.5% | 38.2% | -28.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -6.9% | -8.9% | -12.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -4.3% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $236M | $160M | $195M | $292M | $212M | $295M | $335M | $208M | $181M | $2M | $0 | $0 | |
| Net Income TTM | $-5M | $-69M | $-52M | $-94M | $-282M | $-385M | $-280M | $-144M | $-74M | $-136M | $-61M | $-37M | |
| Market Cap | $427M | $427M | $241M | · | $400M | $415M | $769M | $646M | $708M | $402M | $396M | $237M | |
| Enterprise Value | $291M | $414M | $233M | · | $348M | $282M | $697M | · | · | · | · | · | |
| P/E | -80.5 | -5.8 | -4.4 | -1.1 | -1.3 | -1.0 | -2.7 | -3.0 | -8.0 | · | · | · | |
| P/S | 1.8 | 2.7 | 1.2 | · | 1.9 | 1.4 | 2.3 | 3.1 | 3.9 | 261.9 | · | · | |
| P/B | 13.1 | -8.7 | -7.9 | · | 5.2 | 1.7 | 1.9 | 1.0 | 5.9 | 5.9 | 3.0 | 2.3 | |
| P / Tangible Book | · | · | · | · | · | 9.2 | · | · | · | · | · | · | |
| P / Cash Flow | 6.3 | -10.5 | -10.3 | · | -1.6 | -3.8 | -3.0 | -6.6 | -12.6 | 6.9 | -7.6 | -8.6 | |
| P / FCF | 6.3 | -10.5 | -10.3 | · | -1.6 | -3.7 | -2.9 | -6.5 | -12.3 | 7.3 | -7.5 | -8.6 | |
| EV / EBITDA | 12.4 | -8.2 | -5.0 | · | -1.3 | -0.8 | -2.5 | · | · | · | · | · | |
| EV / FCF | 4.3 | -10.2 | -10.0 | · | -1.4 | -2.5 | -2.6 | · | · | · | · | · | |
| EV / Revenue | 1.2 | 2.6 | 1.2 | · | 1.6 | 1.0 | 2.1 | · | · | · | · | · | |
| Earnings Yield | -1.2% | -17.4% | -22.6% | -90.1% | -75.2% | -99.3% | -37.3% | -33.6% | -12.5% | · | · | · |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $49M | $54M | $58M | $59M | $62M | $57M | $46M | $37M | $44M | $33M | $56M | $42M | $56M | $40M | $56M | $49M | |
| Cost of Revenue | $10M | $12M | $13M | $9M | $10M | $8M | $20M | $14M | $17M | $12M | $19M | $18M | $17M | $20M | $-3M | $38M | |
| R&D Expense | $14M | $15M | $27M | $15M | $11M | $10M | $12M | $8M | $8M | $10M | $10M | $13M | $20M | $20M | $32M | $28M | |
| SG&A Expense | $28M | $30M | $26M | $29M | $27M | $26M | $28M | $27M | $27M | $25M | $25M | $23M | $27M | $25M | $30M | $32M | |
| Operating Expenses | $45M | $46M | $54M | $45M | $38M | $36M | $40M | $36M | $35M | $36M | $36M | $37M | $48M | $45M | $64M | $61M | |
| Operating Income | $-6M | $-5M | $-9M | $4M | $14M | $14M | $-14M | $-13M | $-9M | $-15M | $1M | $-13M | $-9M | $-26M | $-5M | $-50M | |
| Other Non-op | $-7.0K | $3.0K | $-117.0K | $-10.0K | $-28.0K | $213.0K | $55.0K | $-17.0K | $-39.0K | $95.0K | $658.0K | $-43.0K | $-10.0K | $282.0K | $434.0K | $1M | |
| Pretax Income | $-9M | $-9M | $-11M | $1M | $247.0K | $6M | $-23M | $-20M | $-9M | $-18M | $612.0K | $-14M | $-11M | $-27M | · | · | |
| Income Tax | $70.0K | $126.0K | $1M | $615.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-9M | $-9M | $-12M | $540.0K | $247.0K | $6M | $-23M | $-20M | $-9M | $-18M | $612.0K | $-14M | $-11M | $-27M | $-6M | $-54M | |
| EPS (Basic) | $-0.03 | $-0.03 | $-0.05 | $0.00 | $0.00 | $0.03 | $-0.10 | $-0.10 | $-0.04 | $-0.09 | $0.01 | $-0.08 | $-0.06 | $-0.15 | $-0.04 | $-0.29 | |
| EPS (Diluted) | $-0.03 | $-0.03 | $-0.05 | $0.00 | $0.00 | $0.03 | $-0.10 | $-0.10 | $-0.04 | $-0.09 | $0.01 | $-0.08 | $-0.06 | $-0.15 | $-0.03 | $-0.29 | |
| Shares (Basic) | 269,602,747 | 267,046,755 | -505,691,870 | 264,786,432 | 262,565,500 | 235,497,720 | -414,062,349 | 210,348,459 | 209,705,397 | 204,955,151 | -372,427,316 | 188,306,350 | 186,817,431 | 184,768,983 | -364,296,577 | 183,882,446 | |
| Shares (Diluted) | 269,602,747 | 267,046,755 | -529,921,813 | 274,372,722 | 271,104,020 | 241,602,853 | -414,062,349 | 210,348,459 | 209,705,397 | 204,955,151 | -372,427,316 | 188,306,350 | 186,817,431 | 184,768,983 | -371,074,128 | 183,882,446 | |
| EBITDA | $-6M | $-5M | · | $4M | $14M | $14M | · | $-13M | $-9M | $-15M | · | $-13M | $-9M | $-25M | · | $-48M |
Bilans 25
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $163M | $185M | $166M | $137M | $113M | $52M | $34M | $39M | $42M | $43M | $47M | $54M | $57M | $90M | $145M | |
| Receivables | $54M | $63M | $47M | $66M | $73M | $62M | $34M | $32M | $30M | $27M | · | $23M | $20M | $18M | $40M | $23M | |
| Inventory | $13M | $13M | $16M | $19M | $17M | $20M | $16M | $20M | $24M | $26M | · | $18M | $21M | $21M | $22M | $40M | |
| Prepaid Expense | $7M | $5M | $5M | $7M | $8M | $9M | $11M | $13M | $19M | $19M | · | $22M | $24M | $25M | $33M | $30M | |
| Other Current Assets | $6M | $4M | $4M | $5M | $8M | $8M | $7M | $6M | $7M | $5M | · | · | · | · | $17M | · | |
| Current Assets | $230M | $243M | $253M | $258M | $235M | $204M | $114M | $100M | $112M | $113M | · | $110M | $118M | $121M | $185M | $238M | |
| PP&E (Net) | $2M | $956.0K | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | · | $4M | $4M | $5M | $5M | $6M | |
| Goodwill | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | · | $59M | $59M | $55M | $59M | $55M | |
| Intangibles | · | · | · | · | · | · | · | $9M | $18M | $27M | · | $45M | $54M | $63M | $72M | $81M | |
| Other Non-current Assets | $54M | $57M | $60M | $40M | $44M | $38M | $37M | $27M | $18M | $12M | · | $4M | $3M | $5M | $5M | $26M | |
| Total Assets | $350M | $363M | $377M | $364M | $346M | $310M | $221M | $207M | $220M | $225M | · | $235M | $254M | $277M | $356M | $436M | |
| Accounts Payable | $9M | $8M | $21M | $10M | $12M | $13M | $15M | $13M | $10M | $12M | · | $9M | $12M | $13M | $18M | $20M | |
| Accrued Liabilities | $110M | $125M | $122M | $106M | $92M | $71M | $63M | $52M | $54M | $54M | · | $63M | $56M | $46M | $76M | $87M | |
| Current Liabilities | $161M | $174M | $163M | $133M | $119M | $91M | $81M | $66M | $107M | $66M | · | $80M | $92M | $83M | $130M | $188M | |
| Capital Leases | $4M | · | $0 | $0 | $671.0K | $2M | $4M | $5M | $6M | $8M | · | $10M | $11M | $27M | $29M | $31M | |
| Other Non-current Liabilities | $562.0K | $681.0K | $2M | $5M | $5M | $5M | $5M | $5M | $7M | $7M | · | $9M | $17M | $13M | $16M | $74M | |
| Total Liabilities | $325M | $335M | $344M | $323M | $316M | $286M | $270M | $258M | $254M | $253M | · | $274M | $281M | $291M | $351M | $422M | |
| Long-term Debt | $50M | $49M | $48M | $48M | $47M | $47M | · | $38M | $38M | $30M | · | $43M | $42M | $50M | $66M | $66M | |
| Total Debt | $50M | $49M | · | $48M | $47M | $47M | · | $38M | $38M | $30M | · | $43M | $42M | $50M | · | $66M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | · | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-1.70B | $-1.69B | $-1.68B | $-1.67B | $-1.67B | $-1.67B | $-1.68B | $-1.66B | $-1.64B | $-1.63B | · | $-1.61B | $-1.60B | $-1.58B | $-1.56B | $-1.55B | |
| AOCI | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Stockholders' Equity | $25M | $27M | $33M | $42M | $29M | $25M | $-49M | $-50M | $-34M | $-27M | $-31M | $-39M | $-27M | $-14M | $5M | $14M | |
| Liabilities + Equity | $350M | $363M | $377M | $364M | $346M | $310M | $221M | $207M | $220M | $225M | · | $235M | $254M | $277M | $356M | $436M | |
| Shares Outstanding | 271,742,717 | 267,898,415 | 265,424,818 | 265,226,038 | 263,041,832 | 261,644,590 | 224,848,992 | 211,542,122 | 209,929,145 | 209,454,149 | 194,582,539 | 188,313,807 | 188,128,869 | 185,835,946 | 184,135,714 | 183,951,583 |
Przepływy pieniężne 9
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | |
| Amort. of Intangibles | · | · | $0 | $0 | $0 | $0 | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Restructuring | $2M | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $58.0K | $0 | $169.0K | $-94.0K | $106.0K | $1M | $180.0K | |
| Operating Cash Flow | $4M | $-21M | $31M | $28M | $22M | $-14M | $-4M | $-7M | $-10M | $-19M | $-2M | $-7M | $4M | $-18M | $-55M | $34M | |
| CapEx | $1M | $62.0K | $70.0K | $77.0K | $126.0K | $18.0K | $2.0K | $2.0K | $29.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Investing Cash Flow | $-4M | $-62.0K | $-8M | $-77.0K | $-126.0K | $154.0K | $-2.0K | $-2.0K | $-29.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $-7M | $-926.0K | $-5M | $1M | $2M | $75M | $22M | $1M | $8M | $18M | $-1M | $50.0K | $-8M | $-16M | $-1.0K | $-33M | |
| Net Change in Cash | $-7M | $-22M | $18M | $29M | $24M | $62M | $18M | $-5M | $-2M | $-957.0K | $-4M | $-7M | $-4M | $-34M | $-55M | $868.0K | |
| Free Cash Flow | · | $-21M | · | · | · | $-14M | · | · | · | · | · | · | · | $-18M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -12.9% | -8.8% | · | 7.6% | 22.6% | 23.6% | · | -33.4% | -20.0% | -45.8% | · | -31.0% | -16.0% | -62.2% | · | -98.4% | |
| Net Margin | -18.1% | -16.9% | · | 0.92% | 0.40% | 10.7% | · | -53.5% | -19.7% | -55.2% | · | -34.5% | -19.8% | -65.3% | · | -105.9% | |
| Pretax Margin | -18.0% | -16.7% | · | 2.0% | 0.40% | 10.7% | · | -53.5% | -19.7% | -55.2% | · | · | · | · | · | · | |
| EBITDA Margin | -12.9% | -8.8% | · | 7.6% | 22.6% | 23.6% | · | -33.4% | -20.0% | -45.8% | · | -31.0% | -16.0% | -62.2% | · | -98.4% | |
| ROA | -2.6% | -2.7% | · | 0.19% | 0.09% | 2.3% | · | -9.1% | -3.6% | -7.2% | · | -4.3% | -2.9% | -6.5% | · | -10.0% | |
| ROE | -32.9% | -34.8% | · | -12.3% | -10.9% | -456.6% | · | 44.6% | 28.3% | 86.5% | · | 113.3% | -62.9% | -445.7% | · | -68.7% | |
| ROIC | -8.6% | -6.2% | · | 2.3% | · | · | · | · | · | · | · | · | · | · | · | · |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.9 | 2.0 | 2.2 | · | 1.5 | 1.0 | 1.7 | · | 1.4 | 1.3 | 1.5 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.7 | 1.8 | 1.9 | · | 1.0 | 0.6 | 1.0 | · | 0.9 | 0.8 | 0.9 | · | 0.9 | |
| Debt / Equity | 2.0 | 1.8 | · | 1.1 | 1.6 | 1.9 | · | -0.8 | -1.1 | -1.1 | · | -1.1 | -1.6 | -3.5 | · | 4.8 | |
| LT Debt / Equity | 1.0 | 1.3 | · | 1.1 | 1.6 | 1.9 | · | -0.8 | -1.1 | -1.1 | · | -0.9 | -0.7 | -1.8 | · | · |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.3 | · | 0.7 | 0.8 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 1.0 | |
| Receivables Turnover | 0.8 | 0.9 | · | 1.2 | 1.2 | 1.3 | · | 1.4 | 1.8 | 1.5 | · | 1.8 | 1.1 | 1.0 | · | 1.3 |
Wycena (TTM) 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $224M | $232M | · | $216M | $201M | $171M | · | $156M | $175M | $171M | · | $187M | $271M | $277M | · | $286M | |
| Net Income TTM | $-17M | $-2M | · | $-13M | $-22M | $-40M | · | $-61M | $-52M | $-71M | · | $-107M | $-63M | $-115M | · | $-148M | |
| Market Cap | $310M | $372M | · | $724M | $957M | $502M | · | $279M | $214M | $383M | · | $215M | $172M | $104M | · | $58M | |
| Enterprise Value | $204M | $259M | · | $605M | $867M | $435M | · | $284M | $213M | $371M | · | $211M | $161M | $97M | · | $-21M | |
| P/E | -19.0 | · | · | -39.0 | -33.1 | -9.6 | · | -4.3 | -3.8 | -4.8 | · | -2.0 | -2.6 | -0.9 | · | -0.4 | |
| P/S | 1.4 | 1.6 | · | 3.4 | 4.8 | 2.9 | · | 1.8 | 1.2 | 2.2 | · | 1.1 | 0.6 | 0.4 | · | 0.2 | |
| P/B | 12.4 | 13.6 | · | 17.4 | 32.8 | 20.4 | · | -5.5 | -6.3 | -14.1 | · | -5.4 | -6.4 | -7.3 | · | 4.2 | |
| P / Cash Flow | · | -17.6 | · | · | · | -37.0 | · | · | · | -19.7 | · | · | · | -5.9 | · | · | |
| P / FCF | · | -17.5 | · | · | · | -36.9 | · | · | · | · | · | · | · | -5.9 | · | · | |
| EV / EBITDA | -32.2 | -55.1 | · | 136.0 | 61.6 | 32.2 | · | -22.7 | -24.4 | -24.9 | · | -16.2 | -17.9 | -3.9 | · | 0.4 | |
| EV / FCF | · | -12.2 | · | · | · | -32.0 | · | · | · | · | · | · | · | -5.6 | · | · | |
| EV / Revenue | 0.9 | 1.1 | · | 2.8 | 4.3 | 2.5 | · | 1.8 | 1.2 | 2.2 | · | 1.1 | 0.6 | 0.4 | · | -0.1 | |
| Earnings Yield | -5.3% | 0.00% | · | -2.6% | -3.0% | -10.4% | · | -23.5% | -26.5% | -20.8% | · | -50.9% | -38.2% | -114.3% | · | -262.7% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 | |
|---|---|---|---|---|---|
| Przychody | $236M | $160M | $195M | — | $292M |
| Marża Operacyjna % | 10.0% | -31.5% | -23.8% | — | -27.6% |
| Zysk netto | $-5M | $-69M | $-52M | — | $-94M |
| Rozwodniony EPS | $-0.02 | $-0.33 | $-0.28 | — | $-0.52 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 1.5 | -0.8 | -1.1 | — | — |
| Wskaźnik bieżący | 1.6 | 1.4 | 1.2 | — | — |
| Wskaźnik Szybkości | 1.4 | 1.1 | 0.8 | — | — |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $68M | $-41M | $-23M | — | $-73M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 184 emitenci · $87.7M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 43 (+12 vs poprzedni kw.) | 35 (+9 vs poprzedni kw.) | 59 (+14 vs poprzedni kw.) | 36 (-14 vs poprzedni kw.) | +11.5M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $12 907 243 | 11 322 143 | 14,72% | Akcje |
| SATTER MANAGEMENT CO., L.P. | $10 921 021 | 5 747 906 | 12,45% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $6 557 737 | 5 750 625 | 7,48% | Akcje |
| STATE STREET CORP | $6 145 572 | 5 390 853 | 7,01% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $4 871 250 | 4 273 026 | 5,55% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $3 644 130 | 3 196 605 | 4,15% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 888 734 | 2 533 977 | 3,29% | Akcje |
| GOLDMAN SACHS GROUP INC | $2 779 842 | 2 438 458 | 3,17% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $2 777 807 | 2 436 673 | 3,17% | Akcje |
| VANGUARD GROUP INC | $2 715 740 | 1 686 795 | 3,10% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2 622 499 | 2 300 438 | 2,99% | Akcje |
| Nantahala Capital Management, LLC | $2 280 000 | 2 000 000 | 2,60% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $2 176 029 | 1 908 797 | 2,48% | Akcje |
| FMR LLC | $2 132 467 | 1 870 585 | 2,43% | Akcje |
| Qube Research & Technologies Ltd | $2 028 866 | 1 779 707 | 2,31% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $1 395 318 | 1 223 963 | 1,59% | Akcje |
| CITIGROUP INC | $1 265 009 | 1 109 657 | 1,44% | Akcje |
| MANGROVE PARTNERS IM, LLC | $760 328 | 666 954 | 0,87% | Akcje |
| AMERIPRISE FINANCIAL INC | $703 205 | 616 846 | 0,80% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $672 396 | 589 821 | 0,77% | Akcje |
| TWO SIGMA ADVISERS, LP | $643 918 | 399 949 | 0,73% | Akcje |
| CHOREO, LLC | $641 162 | 562 423 | 0,73% | Akcje |
| Quantinno Capital Management LP | $640 820 | 562 123 | 0,73% | Akcje |
| Creative Planning | $622 144 | 545 740 | 0,71% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $606 265 | 531 813 | 0,69% | Akcje |
| MORGAN STANLEY | $584 591 | 512 799 | 0,67% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $531 832 | 466 519 | 0,61% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $493 325 | 354 910 | 0,56% | Akcje |
| Eversept Partners, LP | $486 888 | 427 095 | 0,56% | Akcje |
| BANK OF AMERICA CORP /DE/ | $473 308 | 415 182 | 0,54% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $368 904 | 323 600 | 0,42% | Akcje |
| VIRTUS ADVISERS, LLC | $359 940 | 315 737 | 0,41% | Akcje |
| RHUMBLINE ADVISERS | $350 544 | 307 503 | 0,40% | Akcje |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $336 186 | 294 900 | 0,38% | Akcje |
| ALPS ADVISORS INC | $310 379 | 272 262 | 0,35% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $307 391 | 269 641 | 0,35% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $304 722 | 267 300 | 0,35% | Opcja sprzedaży |
| FRANKLIN RESOURCES INC | $286 156 | 251 014 | 0,33% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $279 072 | 244 800 | 0,32% | Opcja kupna |
| Vanguard Global Advisers, LLC | $251 440 | 220 561 | 0,29% | Akcje |
| Graham Capital Management, L.P. | $236 845 | 207 759 | 0,27% | Akcje |
| Bank of New York Mellon Corp | $227 323 | 199 406 | 0,26% | Akcje |
| Wealthspire Advisors, LLC | $205 203 | 180 002 | 0,23% | Akcje |
| CITADEL ADVISORS LLC | $190 608 | 167 200 | 0,22% | Opcja sprzedaży |
| BlackRock, Inc. | $189 909 | 166 587 | 0,22% | Akcje |
| Nuveen Asset Management, LLC | $186 464 | 98 139 | 0,21% | Akcje |
| Man Group plc | $177 151 | 155 396 | 0,20% | Akcje |
| Mariner, LLC | $175 851 | 154 256 | 0,20% | Akcje |
| MetLife Investment Management, LLC | $174 281 | 152 878 | 0,20% | Akcje |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $157 464 | 112 474 | 0,18% | Akcje |
| Russell Investments Group, Ltd. | $143 655 | 126 014 | 0,16% | Akcje |
| BARCLAYS PLC | $139 430 | 122 307 | 0,16% | Akcje |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $136 850 | 85 000 | 0,16% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $135 666 | 119 005 | 0,15% | Akcje |
| MERCER GLOBAL ADVISORS INC /ADV | $127 402 | 111 756 | 0,15% | Akcje |
| Invesco Ltd. | $116 967 | 102 603 | 0,13% | Akcje |
| GROUP ONE TRADING LLC | $115 841 | 101 615 | 0,13% | Akcje |
| Fiduciary Trust Co | $114 000 | 100 000 | 0,13% | Akcje |
| CITADEL ADVISORS LLC | $110 580 | 97 000 | 0,13% | Opcja kupna |
| LPL Financial LLC | $108 888 | 95 516 | 0,12% | Akcje |
| IEQ CAPITAL, LLC | $105 312 | 92 379 | 0,12% | Akcje |
| Jain Global LLC | $104 214 | 91 416 | 0,12% | Akcje |
| Focus Partners Wealth | $92 280 | 80 948 | 0,11% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $91 133 | 79 941 | 0,10% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $90 174 | 79 100 | 0,10% | Akcje |
| Headlands Technologies LLC | $88 911 | 77 992 | 0,10% | Akcje |
| Abel Hall, LLC | $85 999 | 75 438 | 0,10% | Akcje |
| SEI INVESTMENTS CO | $84 797 | 74 383 | 0,10% | Akcje |
| D. E. Shaw & Co., Inc. | $82 699 | 72 543 | 0,09% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $81 957 | 71 892 | 0,09% | Akcje |
| OSAIC HOLDINGS, INC. | $79 715 | 69 926 | 0,09% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $78 757 | 69 085 | 0,09% | Akcje |
| Brevan Howard Capital Management LP | $72 675 | 63 750 | 0,08% | Akcje |
| CITADEL ADVISORS LLC | $72 243 | 63 371 | 0,08% | Akcje |
| INTECH INVESTMENT MANAGEMENT LLC | $70 931 | 62 220 | 0,08% | Akcje |
| Squarepoint Ops LLC | $67 747 | 59 427 | 0,08% | Akcje |
| CWA Asset Management Group, LLC | $67 260 | 59 000 | 0,08% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $65 585 | 57 531 | 0,07% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $63 105 | 55 355 | 0,07% | Akcje |
| Arax Advisory Partners | $62 700 | 54 999 | 0,07% | Akcje |
| VOYA INVESTMENT MANAGEMENT LLC | $61 941 | 54 334 | 0,07% | Akcje |
| CAPTRUST FINANCIAL ADVISORS | $61 567 | 54 006 | 0,07% | Akcje |
| JANE STREET GROUP, LLC | $59 280 | 52 000 | 0,07% | Opcja kupna |
| PDS Planning, Inc | $57 000 | 50 000 | 0,06% | Akcje |
| Nuveen, LLC | $56 925 | 49 934 | 0,06% | Akcje |
| UBS Group AG | $52 834 | 46 346 | 0,06% | Akcje |
| PRUDENTIAL FINANCIAL INC | $50 028 | 43 884 | 0,06% | Akcje |
| NORTHERN TRUST CORP | $46 146 | 40 479 | 0,05% | Akcje |
| TWO SIGMA SECURITIES, LLC | $45 753 | 40 134 | 0,05% | Akcje |
| EP Wealth Advisors, LLC | $44 059 | 38 648 | 0,05% | Akcje |
| HighTower Advisors, LLC | $43 968 | 38 568 | 0,05% | Akcje |
| Gotham Asset Management, LLC | $41 100 | 36 053 | 0,05% | Akcje |
| Scientech Research LLC | $40 117 | 35 190 | 0,05% | Akcje |
| Empirical Asset Management, LLC | $39 900 | 35 000 | 0,05% | Akcje |
| ProShare Advisors LLC | $38 572 | 33 836 | 0,04% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $37 783 | 33 143 | 0,04% | Akcje |
| CWM, LLC | $36 332 | 26 138 | 0,04% | Akcje |
| Tower Research Capital LLC (TRC) | $35 706 | 31 321 | 0,04% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $34 394 | 30 170 | 0,04% | Akcje |
| Sonora Investment Management Group, LLC | $32 760 | 12 000 | 0,04% | Akcje |
Insiderzy spółki 29 insiderów · 9 dyrektorzy generalni · 17 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Erik Ostrowski | SVP, CFO, CBO & Treasurer | 29 czerwca 2026 S | 616 616 | 0 | 1 | $-62 181 |
| David A Spellman | SVP, CFO and Treasurer | 30 czerwca 2020 A | — | 0 | 0 | $0 |
| Jason Amello | SVP, CFO & Treasurer | 11 kwietnia 2019 D | 118 618 | 0 | 0 | $0 |
| Rita Jain | SVP, Chief Medical Officer | 11 kwietnia 2019 D | 96 332 | 0 | 0 | $0 |
| Michel Dahan | SVP, Chief Business Officer | 11 kwietnia 2019 D | 146 932 | 0 | 0 | $0 |
| Nicole R. Hadas | SVP, CLO & Secretary | 11 kwietnia 2019 D | 154 806 | 0 | 0 | $0 |
| Karen L Tubridy | SVP, Chief Development Officer | 11 kwietnia 2019 D | 55 324 | 0 | 0 | $0 |
| Bradley Maroni | SVP and Chief Medical Officer | 22 lutego 2016 A | 38 859 | 0 | 0 | $0 |
| Robert Shalwitz | Chief Medical Officer | 14 maja 2014 A | 264 556 | 0 | 0 | $0 |
| Ron Frieson | Dyrektor | 17 czerwca 2026 A | 165 200 | 0 | 0 | $0 |
| Myles Wolf | Dyrektor | 17 czerwca 2026 A | 169 081 | 0 | 0 | $0 |
| Cynthia Smith | Dyrektor | 17 czerwca 2026 A | 196 633 | 0 | 0 | $0 |
| Adrian Adams | Dyrektor | 17 czerwca 2026 A | 236 200 | 0 | 0 | $0 |
| Michael W Rogers | Dyrektor | 17 czerwca 2026 A | 197 429 | 0 | 0 | $0 |
| Leanne M Zumwalt | Dyrektor | 17 czerwca 2026 A | 145 100 | 0 | 0 | $0 |
| Jodie Pope Morrison | Dyrektor | 12 grudnia 2018 A | 44 919 | 0 | 0 | $0 |
| Mark J Enyedy | Dyrektor | 12 grudnia 2018 A | 3 743 | 0 | 0 | $0 |
| Michael Thomas Heffernan | Dyrektor | 12 grudnia 2018 A | 7 486 | 0 | 0 | $0 |
| Steven C Gilman | Dyrektor | 12 grudnia 2018 A | 10 231 | 0 | 0 | $0 |
| Satter Muneer A | Dyrektor | 5 lipca 2017 P | 3 037 042 | 0 | 0 | $0 |
| Duane Nash | Dyrektor | 2 października 2015 S | 31 609 | 0 | 0 | $0 |
| Anupam Dalal | Dyrektor | 10 czerwca 2015 A | — | 0 | 0 | $0 |
| Michael D. Clayman | Dyrektor | 10 czerwca 2015 A | — | 0 | 0 | $0 |
| Ronald C Renaud JR | Dyrektor | 10 czerwca 2015 A | 5 000 | 0 | 0 | $0 |
| Maxine Gowen | Dyrektor | 10 czerwca 2015 A | 1 300 | 0 | 0 | $0 |
| Michael S Wyzga | Dyrektor | 10 czerwca 2015 A | 1 500 | 0 | 0 | $0 |
| John P. Butler | — | 6 sierpnia 2026 M | 3 718 564 | 0 | 0 | $0 |
| Novo Holdings A/S | — | 25 marca 2014 C | 1 516 387 | 0 | 0 | $0 |
| Novartis Bioventures Ltd | — | 25 marca 2014 C | 3 405 764 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 5 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Muneer A. Satter (2) ×3 zgłoszenia | 11 stycznia 2019 | — | Pierwotne zgłoszenie | — | SEC |
| Nantahala Capital Management, LLC, Wilmot B. Harkey, Daniel Mack ×2 zgłoszenia | 21 grudnia 2018 | — | Pierwotne zgłoszenie | — | SEC |
| Vifor (International) Ltd., Vifor Pharma Ltd. ×2 zgłoszenia | 10 sierpnia 2017 | — | Pierwotne zgłoszenie | — | SEC |
| Kearny Venture Partners, L.P. (“KVP”), Kearny Venture Partners Entrepreneurs’ Fund, L.P. (“KVPE”), Thomas Weisel Healthcare Venture Partners, L.P. (“TWHVP”), Kearny Venture Associates, L.L.C. (“KVA”), Caley Castelein (“Castelein”), Richard Spalding (“Spalding”), James Shapiro (“Shapiro”) ×2 zgłoszenia | 20 stycznia 2016 | — | Pierwotne zgłoszenie | — | SEC |
| Novo A/S ×3 zgłoszenia | 18 listopada 2015 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 30 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,44% | 109 760 SH | 8 sierpnia 2026 | Dziennie |
| SBIO · ALPS ETF Trust | 0,17% | 276 121 NS | 31 maja 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,09% | 352 079 NS | 30 kwietnia 2026 | N-PORT |
| IWC · iShares Trust | 0,06% | 879 437 SH | 8 sierpnia 2026 | Dziennie |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 326 417 NS | 31 maja 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 249 458 SH | 8 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 450 395 SH | 8 sierpnia 2026 | Dziennie |
| SMLF · iShares Trust | 0,01% | 617 659 SH | 8 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | 0,01% | 2 117 247 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 111 420 NS | 30 kwietnia 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 1 485 665 SH | 8 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,01% | 6 655 005 SH | 8 sierpnia 2026 | Dziennie |
| ITWO · ProShares Trust | 0,01% | 11 916 NS | 31 maja 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 1 262 655 NS | 31 maja 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 9 319 NS | 31 maja 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 9 423 NS | 31 maja 2026 | N-PORT |
| IWN · iShares Trust | 0,00% | 337 593 SH | 8 sierpnia 2026 | Dziennie |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 11 769 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 237 NS | 31 maja 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 364 360 SH | 8 sierpnia 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,00% | 108 459 NS | 30 kwietnia 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 6 918 NS | 30 kwietnia 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 45 708 SH | 8 sierpnia 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,00% | 6 798 NS | 30 kwietnia 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 11 776 NS | 30 kwietnia 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 3 164 884 SH | 8 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 7 912 283 SH | 8 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 24 210 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 20 230 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,00% | 754 414 SH | 8 sierpnia 2026 | Dziennie |